A Specific COVID-19 Call in the MRFF Biomedical Translation Bridge (BTB Program, Round 3) - NOW OPEN (ONLY 2 WEEKS TO PREPARE THE EoI)

This scheme can provide up to $1 million to support eligible organisations develop medical device, diagnostics, prophylactic or therapeutic approaches that will achieve an impact on the global response to the pandemic in less than 12 months. Applicants must have matching funds from another source (cash, not in-kind).

Media Release
This BTB program Round will fund COVID-19 projects with:

• A clear value proposition for the proposed medical device product or prophylactic or therapeutic approach;
• Differentiating features from currently available solutions or those in clinical development nationally and on the global market; and
• Delivery of impact in the current pandemic in less than 12 months.

For this Special BTB Round, the key differences are:

• Matched funding must be available immediately.
• No mentoring. Shortlisted EOIs will progress directly to Proposal submission.  BTB Venture Partners will assist with the preparation of the confidential proposal.

Further information is provided on the BTB webpage, including guidelines, templates and FAQs 

The expected key dates are:

ACTIVITY	TIMEFRAME
R3 EOI Application	18 May – 1 June 2020
R3 EOI Outcomes	Late-June 2020
R3 Stage 2 Proposal	Late-June – Mid-July 2020
R3 Stage 2 Outcomes	Late July 2020
Contracting Project Start Date Project End Date	August 2020 From 1 September 2020 By 31 August 2021

In you are interested in this call, please email karen.mcconalogue@monash.edu ASAP.